HCA Healthcare stock rises after conference remarks on demand
Published on 09/09/2026 at 23:02 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
HCA Healthcare stock (ISIN US40412C1018) closed at USD 402.02 on September 8, 2026, down 0.74 percent, while its second-quarter 2026 revenue reached USD 20.23 billion and EPS came in at USD 7.59. On September 9, 2026, investors also focused on the company's conference remarks after HCA highlighted 2.1 million adjusted admissions in the first half of 2026 and about 22,000 adjusted admissions that shifted from exchange coverage to uninsured status.
Quarterly numbers still matter
According to MarketBeat, HCA Healthcare reported second-quarter 2026 revenue of USD 20.23 billion and EPS of USD 7.59 on July 24, 2026, versus USD 6.84 a year earlier. The same report said revenue rose 8.7 percent year over year and EPS beat the consensus estimate of USD 7.56 by USD 0.03.
Those figures frame the current debate for investors: HCA is still growing, but the payer-mix shift after the end of enhanced premium tax credits is a clear operating drag. On September 9, 2026, management said 99 percent of the business performed as expected or better than in 2025 and that the core business is running at the high side of its long-term 4 percent to 6 percent EBITDA growth range, according to Investing.com.
Analysts stay constructive
According to MarketBeat, TD Cowen cut its price target on HCA Healthcare to USD 431.00 from USD 500.00 on June 22, 2026, while Barclays reduced its target to USD 387.00 from USD 402.00 on July 27, 2026. The same overview showed a consensus price target of USD 462.64, above the September 8 close of USD 402.02.
That gap is still wide enough to keep the stock on the radar after the latest conference appearance. HCA's quarterly dividend of USD 0.78 per share is scheduled for September 30, 2026, with an ex-dividend date of September 16, 2026, according to Yahoo Finance.
Close and watch list
At the close on September 8, 2026, HCA Healthcare stock stood at USD 402.02 on the NYSE, with a market capitalization of USD 87.04 billion and volume of 1,725,033 shares, according to Yahoo Finance. For now, the combination of a USD 20.23 billion quarter, a USD 7.59 EPS print and a USD 462.64 consensus target keeps the stock tied to execution rather than to headline noise.
HCA Healthcare stock at a glance
- Company: HCA Healthcare, Inc.
- ISIN: US40412C1018
- Ticker: HCA
- Trading venue: NYSE
- Price (as of September 8, 2026): USD 402.02
- Market capitalization: USD 87.04 billion (as of September 9, 2026)
- Sector / Industry: Health Care / Health Care Providers & Services
- Index membership: S&P 500
